SCHEMBL9500534

SCHEMBL9500534

Cc1cc(Cl)cc(Cl)c1S

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 2/20 0.43
ALDH1A1 P00352 4/20 0.41
AHR P35869 2/20 0.38
TSHR P16473 4/20 0.38
CYP3A4 P08684 3/20 0.38
HSD17B10 Q99714 2/20 0.38
RECQL P46063 1/20 0.38
HPGD P15428 2/20 0.33
HTT P42858 2/20 0.33
CD44 P16070 1/20 0.33
CES1 P23141 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1392834 0.80 ALDH1A1 (0.53) ALDH1A1AHRTSHRCYP3A4HSD17B10
SCHEMBL11014169 0.75 CYP3A4 (0.48) ALDH1A1TSHRCYP3A4CD44TP53
SCHEMBL4304036 0.72 ALDH1A1 (0.45) ALDH1A1AHRTSHRCYP3A4HSD17B10
SCHEMBL180195 0.72 ALDH1A1 (0.61) RAPGEF4ALDH1A1AHRTSHRCYP3A4
SCHEMBL1828947 0.72 RAPGEF4 (0.46) RAPGEF4ALDH1A1AHRTSHRCYP3A4
SCHEMBL29351204 0.72 ALDH1A1 (0.61) RAPGEF4ALDH1A1AHRTSHRCYP3A4
SCHEMBL1505303 0.70 RAPGEF4 (0.45) RAPGEF4ALDH1A1AHRTSHRCYP3A4
SCHEMBL28475506 0.70 ALDH1A1 (0.43) ALDH1A1AHRTSHRCYP3A4HSD17B10
SCHEMBL28753398 0.70 SHBG (0.34) MAPT
SCHEMBL23699497 0.69 AKR1C4 (0.47) ALDH1A1TSHRCYP3A4HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2613878-B1 NOVEL OLEFIN METATHESIS CATALYSTS BERGEN TEKNOLOGIOVERFØRING AS (NO) 2016-07-27 EP disclosed
US-8716488-B2 Olefin metathesis catalysts BERGEN TEKNOLOGIOVERFORING AS (NO) 2014-05-06 US disclosed
US-20130023665-A1 NOVEL OLEFIN METATHESIS CATALYSTS BERGEN TEKNOLOGIOVERFORING AS (NO) 2013-01-24 US disclosed
EP-0544732-A1 IMPROVED PROCESS FOR PREPARATION OF PHOSPHORODICHLOROTHIOATES WEHRENBERG, Peter K. (US) 1993-06-09 EP disclosed
WO-1992003447-A1 IMPROVED PROCESS FOR PREPARATION OF PHOSPHORODICHLOROTHIOATES WEHRENBERG PETER K (US) 1992-03-05 WO disclosed
US-5081272-A PROCESS FOR PREPARATION OF PHOSPHORODICHLOROTHIOATES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-14 US disclosed
US-4727178-A Process for preparing phosphorodichloridothiolate STAUFFER CHEMICAL CO. (US) 1988-02-23 US disclosed
US-4056581-A Process for the preparation of phosphorodichloridothiolates ROHM AND HAAS COMPANY (US) 1977-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130023665-A1 NOVEL OLEFIN METATHESIS CATALYSTS OCIAD2, OCIAD1, OXER1 RAPGEF4 773/4885ALDH1A1 1398/4885AHR 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.